Zhejiang Genfleet Therapeutics Co., Ltd.
4 clinical trials · Sponsor
◉ Watch Zhejiang Genfleet Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC) (NCT05618691) | Zhejiang Genfleet Therapeutics Co., Ltd. | 2022-12-01 |
| A Phase I Study of GFH312 in Healthy Chinese Subjects (NCT05991362) | Zhejiang Genfleet Therapeutics Co., Ltd. | 2022-11-29 |
| A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors (NCT05165849) | Zhejiang Genfleet Therapeutics Co., Ltd. | 2022-04-01 |
| A Study of GFH018 in Patients With Advanced Solid Tumors (NCT05051241) | Zhejiang Genfleet Therapeutics Co., Ltd. | 2019-08-30 |
Track Zhejiang Genfleet Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.